Personality Disorders

Genetic and constitutional (non-modifiable)

• Heritable temperament: traits such as impulsivity, harm avoidance, and affective instability are substantially heritable and predate any diagnosable disorder; the disorder emerges when trait extremes meet stress.
• Family loading for schizophrenia spectrum: schizotypal (and to a lesser degree paranoid/schizoid) personality disorder aggregates in relatives of patients with schizophrenia — DSM-5-TR explicitly places schizotypal within the schizophrenia spectrum.
• Gene × maltreatment interaction: the classic exam example is low-activity MAOA genotype plus childhood maltreatment predicting antisocial behavior — neither factor alone is sufficient.
• Sex and developmental factors: antisocial personality disorder is diagnosed far more often in males; borderline is diagnosed more often in females in clinical samples. Prenatal exposures (maternal smoking, alcohol) and early frontal traumatic brain injury raise risk for disinhibited, antisocial presentations.

Environmental and developmental (potentially modifiable)

• Childhood adversity: physical/sexual abuse, neglect, and household dysfunction — the CDC's adverse childhood experiences framework — are the most consistently planted stem detail, particularly for borderline personality disorder.
• Invalidating environment: Linehan's biosocial model, the theoretical basis for DBT — an emotionally vulnerable child in a caregiving environment that punishes or dismisses emotional expression fails to learn emotion regulation.
• Disrupted attachment and caregiving instability: multiple foster placements, parental loss, parental substance use or incarceration.
• Untreated childhood psychopathology: conduct disorder before age 15 is a diagnostic prerequisite for antisocial personality disorder; ADHD and early substance use accelerate the trajectory.
• Ongoing substance use and intimate partner violence: these amplify and perpetuate impulsive, unstable patterns and are the modifiable targets available to the clinician in adulthood.

• Neurotransmitter dysregulation: Abnormalities in serotonergic, dopaminergic, and GABAergic systems contribute to impulsivity, emotional dysregulation, and aggression; specific patterns vary by cluster (e.g., low serotonin in impulsive cluster B disorders)

• Neuroimaging findings: Reduced prefrontal cortex volume and activity, particularly in orbitofrontal and anterior cingulate cortices, impairs judgment, impulse control, and emotional regulation; amygdala hyperactivity contributes to threat sensitivity and emotional reactivity

• Attachment and developmental trauma: Early childhood experiences including neglect, abuse, inconsistent caregiving, or boundary violations create internal working models of self and others that persist into adulthood; disrupted attachment patterns establish maladaptive relational templates

• Temperament and genetic predisposition: Heritable traits including harm avoidance, novelty-seeking, and reward dependence interact with environmental stressors; twin studies suggest 40-60% heritability depending on specific disorder

• Neurobiological stress response: Dysregulated hypothalamic-pituitary-adrenal (HPA) axis and altered cortisol patterns, particularly in Cluster C and trauma-related presentations, create heightened physiologic reactivity to perceived threats

CLUSTER A (Odd/Eccentric) - "Weird"

• Paranoid personality disorder: Pervasive distrust and suspiciousness of others' motives; interprets ambiguous events as hostile; bears grudges; questions loyalty of friends; preoccupied with unsubstantiated fears of exploitation
• Schizoid personality disorder: Detachment from social relationships and restricted emotional expression; prefers solitary activities; indifferent to praise or criticism; appears emotionally cold; no desire for close relationships
• Schizotypal personality disorder: Odd beliefs, magical thinking, or perceptual distortions (but not frank delusions); eccentric behavior or appearance; social anxiety; ideas of reference; occupies the spectrum between normal personality and schizophrenia

CLUSTER B (Dramatic/Emotional) - "Wild"

• Antisocial personality disorder: Violation of others' rights with deceitfulness, impulsivity, and lack of remorse; history of conduct problems; manipulative behavior; callous disregard for safety of others; prominent in forensic populations
• Borderline personality disorder: Intense fear of abandonment (real or imagined); unstable relationships oscillating between idealization and devaluation; unstable self-image; recurrent suicidal behavior, self-harm, or threats; chronic emptiness; inappropriate intense anger; transient paranoia or dissociation under stress
• Histrionic personality disorder: Excessive emotionality and attention-seeking; uncomfortable when not center of attention; rapidly shifting emotions; seductive or provocative behavior; considers relationships more intimate than they are; uses physical appearance to draw attention
• Narcissistic personality disorder: Grandiose sense of self-importance with preoccupation with fantasies of unlimited success; belief in being "special"; requires excessive admiration; sense of entitlement; interpersonally exploitative; envious of others; lacks empathy; arrogant behavior or attitudes

CLUSTER C (Anxious/Fearful) - "Worried"

• Avoidant personality disorder: Social inhibition due to feelings of inadequacy; avoids interpersonal contact due to fear of criticism or rejection; hypersensitive to negative evaluation; reluctant to take risks or try new activities; views self as inferior
• Dependent personality disorder: Difficulty making decisions without excessive advice; needs others to assume responsibility; difficulty disagreeing with others from fear of loss of support; urgency to obtain nurturance from others; feelings of helplessness when alone; preoccupied with fears of abandonment
• Obsessive-compulsive personality disorder: Preoccupation with order, rules, schedules, and efficiency that interferes with task completion; perfectionism interfering with productivity; overdevotedness to work; inflexibility about morality; difficulty delegating; reluctance to spend money; restricted emotional expression

Important clinical pearls about presentation

• Patients typically do not recognize their behavior as problematic; ego-syntonic traits are perceived as normal by the individual
• Presentations often become apparent only in interpersonal stress or when functioning becomes compromised
• Comorbidity with Axis I disorders (depression, anxiety, substance use) is extremely common and often brings patients to treatment
• Cultural context is critical—traits must deviate from cultural norms to meet criteria

• DSM-5 criteria: Diagnosis requires pervasive pattern present across multiple contexts with onset by early adulthood, causing clinically significant distress or impairment; minimum number of criteria (typically 5 of 9) must be met for specific disorders; diagnosis is categorical in DSM-5 but dimensional trait models exist

• Clinical interview: Detailed developmental history, current relationships, work functioning, and specific behavioral examples are essential; collateral information from family members or prior treatment records strengthens diagnosis; longitudinal observation over time increases diagnostic accuracy since acute stress responses can mimic personality pathology

• Structured diagnostic interviews: Standardized instruments such as the Structured Clinical Interview for DSM (SCID-II), Personality Assessment Inventory (PAI), or Minnesota Multiphasic Personality Inventory (MMPI-2) provide objective assessment and reduce diagnostic bias; particularly useful in research and forensic settings

• Differential diagnosis considerations: Distinguish personality disorders from Axis I conditions (depressive episodes, manic episodes, schizophrenia, substance intoxication) which are typically episodic; Personality Change Due to Medical Condition must be ruled out; acute stress or adjustment reactions are time-limited; medication effects (stimulants, corticosteroids) should be assessed

• Important diagnostic considerations:
• No single pathognomonic test exists; diagnosis is clinical
• Avoid diagnosing during acute psychiatric episodes, intoxication, or extreme stress when presentation may not reflect baseline
• Comorbid personality disorders are common (up to 40% of patients with one PD have another)
• Age consideration: Do not diagnose before age 18 except antisocial personality disorder (requires evidence of conduct disorder before age 15)

General Principles

• Psychotherapy is the primary treatment modality; no FDA-approved medications specifically treat personality disorders
• Development of therapeutic alliance is essential but complicated by personality pathology
• Treatment should address both personality dysfunction and concurrent Axis I disorders
• Realistic expectations: Goal is often functional improvement and reduced distress rather than personality "cure"

First-line treatments by cluster

CLUSTER A

• Psychotherapy (supportive or cognitive-behavioral): Low-intensity, structured approaches; focus on practical problem-solving rather than insight-oriented therapy
• Antipsychotics or low-dose SSRIs for schizotypal features or paranoid ideation (e.g., risperidone 0.5-2 mg daily, sertraline 50-200 mg daily)
• Avoid intensive psychotherapy that may increase paranoia

CLUSTER B (most challenging)

• Dialectical Behavior Therapy (DBT): Gold standard; 12-24 month program with individual therapy, skills groups (mindfulness, distress tolerance, emotion regulation, interpersonal effectiveness), phone coaching, and therapist consultation team
• Mentalization-Based Treatment (MBT): 18-24 months focusing on understanding one's own and others' mental states
• Schema Therapy: Long-term (2-3 years) addressing maladaptive early life schemas
• SSRIs for impulsivity and affective instability (sertraline 100-200 mg, paroxetine 40-60 mg daily); limited efficacy
• Topiramate 50-300 mg daily or valproate 500-1500

Emergencies — recognize immediately

• Suicide attempt and completed suicide (borderline, also antisocial and narcissistic): mortality from suicide in borderline personality disorder is markedly elevated above the general population; risk rises acutely after perceived abandonment, rejection, or a narcissistic injury. Any self-harm presentation requires formal suicide risk assessment before disposition — The Joint Commission's National Patient Safety Goal on suicide prevention mandates screening in behavioral health and ED settings. Do not dismiss repeated self-injury as "attention-seeking"; past attempts are the strongest predictor of death by suicide.
• Intentional overdose: prescribing decisions should assume access. Tricyclic antidepressants (cardiotoxic — QRS widening, arrhythmia) and lithium (narrow therapeutic index) are lethal in overdose; limited-quantity dispensing is standard practice.
• Transient stress-related psychosis or dissociation: brief, stress-linked paranoia in borderline personality disorder can be mistaken for a primary psychotic episode; it remits with the stressor rather than requiring long-term antipsychotic therapy.
• Substance intoxication and withdrawal: alcohol/sedative withdrawal with autonomic instability is a true emergency layered on top of the personality diagnosis.

Disease-related complications

• Occupational and relational collapse: job loss, divorce, homelessness, and loss of custody follow from the pervasive interpersonal dysfunction.
• Impulsivity sequelae: unplanned pregnancy, sexually transmitted infection including HIV, motor vehicle trauma, injection-related infection.
• Legal consequences and violence (antisocial): incarceration, victimization of others; assess for weapons access and duty-to-protect obligations.
• Health-system complications: splitting fractures treatment teams into "good" and "bad" clinicians, producing inconsistent care, unnecessary testing, and premature discharge.

Treatment-related complications

• Second-generation antipsychotics: weight gain, dyslipidemia, and hyperglycemia — the ADA/APA consensus supports baseline and serial weight, glucose, and lipid monitoring; also tardive dyskinesia and, rarely, neuroleptic malignant syndrome (fever, rigidity, elevated CK — an emergency).
• Valproate: hepatotoxicity, thrombocytopenia, hyperammonemia, and neural tube defects/reduced IQ with fetal exposure — avoid in patients who may become pregnant, consistent with ACOG guidance on antiepileptic use in reproductive-age women.
• Benzodiazepines: behavioral disinhibition, worsened self-harm, and dependence — generally avoided in borderline personality disorder.
• SSRIs: FDA boxed warning for increased suicidal ideation in patients under 25.

• Ego-syntonic is the defining word: patients see the traits as "just who I am," which is why they present for a comorbid mood, anxiety, or substance disorder rather than for the personality disorder itself. The examiners' favorite contrast is OCPD (ego-syntonic perfectionism, no true obsessions or compulsions) versus OCD (ego-dystonic, intrusive, distressing).
• Splitting on the ward — know the single best next step: when a patient calls one nurse "the only one who understands" and another "incompetent," the answer is a team meeting to set consistent limits and a unified treatment plan, not confrontation of the patient and not a medication change.
• Schizoid versus avoidant: both are socially isolated, but the schizoid patient does not want relationships, while the avoidant patient desperately does and is paralyzed by fear of criticism. Schizotypal adds magical thinking and ideas of reference without frank delusions.
• Antisocial personality disorder has an age rule: diagnosis requires age 18 or older plus documented conduct disorder before age 15 (DSM-5-TR). A 15-year-old with the same behavior gets conduct disorder.
• DBT is the answer for borderline personality disorder: it has the strongest evidence for reducing self-harm and suicidal behavior. Pharmacotherapy is adjunctive and symptom-targeted; no drug is FDA-approved for any personality disorder.
• Do not diagnose during an acute episode: a stem featuring active mania, major depression, intoxication, or an acute stressor is testing whether you will mislabel state as trait. Longitudinal pattern is required.
• Countertransference is a diagnostic clue: the physician who feels rescuing, enraged, bored, or devalued should consider personality pathology — and should respond with consistent boundaries rather than either punitive discharge or special privileges.
• Common distractors: benzodiazepines for the agitated borderline patient (disinhibition, dependence — avoid); insight-oriented or intensive exploratory therapy for paranoid personality disorder (can worsen suspiciousness — use supportive, structured therapy); and reading a brief stress-induced paranoid episode in borderline personality disorder as schizophrenia.